Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma

被引:57
作者
Alexander, MS
Kiser, MM
Culley, T
Kern, JR
Dolan, JW
McChesney, JD
Zygmunt, J
Bannister, SJ
机构
[1] LC Resources Inc, McMinnville, OR 97128 USA
[2] NaPro BioTherapeut, Unit A, Boulder, CO 80301 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2003年 / 785卷 / 02期
关键词
paclitaxel; hydroxy paclitaxel;
D O I
10.1016/S1570-0232(02)00913-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A GLP-validated, sensitive and specific LC-MS-MS method for the quantification of paclitaxel and its 6-alpha- and 3'-p-hydroxy metabolites is presented. A 0.400 ml plasma aliquot is spiked with a C-13(6)-labeled paclitaxel internal standard and extracted with 1 ml methyl-tert.-butyl ether. The ether is evaporated and the residue is reconstituted in 130 mul of 30% aqueous acetonitrile (ACN) containing 0.1% trifluoroacetic acid. Isocratic HPLC analysis is performed by injecting 50 mul of the reconstituted material onto a 50x2.1 mm C-18 column with an ACN-water-acetic acid (50:50:0.1) mobile phase at 200 mul/min flow. Detection is by positive ion electrospray followed by multiple reaction monitoring of the following transitions: paclitaxel (854>509 u), 6-alpha-hydroxy paclitaxel (870>525 u), 3'-p-hydroxy paclitaxel (870>509 u) and internal standard (860>509 u). Quantification is by peak area ratio against the C-13(6) internal standard. The method range is 0.117-117 nM (0.1-100 ng/ml) for paclitaxel and both metabolites using a 0.400 ml human or dog plasma sample. Analysis time per sample is less than 5 min. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:253 / 261
页数:9
相关论文
共 11 条
[1]  
[Anonymous], 2001, BIOAN METH VAL GUID
[2]   EXPEDIENT LIQUID-CHROMATOGRAPHIC ASSAY FOR PACLITAXEL IN PLASMA AFTER ITS ADMINISTRATION TO CANCER-PATIENTS [J].
ELYAZIGI, A ;
YUSUF, A .
THERAPEUTIC DRUG MONITORING, 1995, 17 (05) :511-515
[3]  
HUGHES C, UNPUB J CHROMATOGR B
[4]   Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography [J].
Huizing, MT ;
Sparreboom, A ;
Rosing, H ;
vanTellingen, O ;
Pinedo, HM ;
Beijnen, JH .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 674 (02) :261-268
[5]   Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography [J].
Lee, SH ;
Yoo, SD ;
Lee, KH .
JOURNAL OF CHROMATOGRAPHY B, 1999, 724 (02) :357-363
[6]   PROMOTION OF MICROTUBULE ASSEMBLY INVITRO BY TAXOL [J].
SCHIFF, PB ;
FANT, J ;
HORWITZ, SB .
NATURE, 1979, 277 (5698) :665-667
[7]   ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE, AND PHARMACOKINETIC STUDIES [J].
SHAH, VP ;
MIDHA, KK ;
DIGHE, S ;
MCGILVERAY, IJ ;
SKELLY, JP ;
YACOBI, A ;
LAYLOFF, T ;
VISWANATHAN, CT ;
COOK, CE ;
MCDOWALL, RD ;
PITTMAN, KA ;
SPECTOR, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (03) :309-312
[8]  
SONG D, 1995, J CHROMATOGR B, V663, P337
[9]  
SONNICHSEN DS, 1995, J PHARMACOL EXP THER, V275, P566
[10]  
SPARREBOOM A, 1995, CANCER CHEMOTH PHARM, V36, P299, DOI 10.1007/BF00689047